QVigilance News
28 February 2022
QVigilance supports Rare Disease Day 2022
28 February is Rare Disease Day, and we proudly support this globally-coordinated movement working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease. This year’s video features stories of real people all around the world who are living with a rare disease. Watch the video: […]
21 May 2019
Is Your Pharmacovigilance System Brexit Ready?
In our continued preparations for a no-deal UK exit from the EU (Brexit) and a post-transitionary negotiated deal Brexit, we are pleased to report that we have now successfully completed registration with the MHRA’s ICSR Submissions Portal for all of our existing customers for who we as QVigilance/Quanticate submit Individual Case Safety Reports (ICSRs) and Suspected Unexpected Serious […]
16 January 2019
Quanticate launches QVigilance: a dedicated pharmacovigilance business
Quanticate launches QVigilance: a pharmacovigilance-only service provider LONDON (UK) – (XX) Quanticate, a leading global data-focused clinical research organisation (CRO) has launched QVigilance to provide dedicated pharmacovigilance (PV) and risk management services. QVigilance will be focused on supporting small and mid-size companies transitioning from clinical trials to post-marketing and establishing compliant pharmacovigilance systems. QVigilance offers the full range of global […]